Effect of CXCL8 (200 pg/ml), CCL20 (500 pg/ml), CXCL8-CM, and CCL20-CM on osteoclast formation. by Janak L. Pathak (759122)

Subjects:

CXCL8 (2, 20, and 200 pg/ml) and CCL20 (5, 50, and 500 pg/ml) enhanced Ki-67 gene expression, but only 200 pg/ml of CXCL8 and 500 pg/ml of CCL20 enhanced early osteogenic marker ge... by Janak L. Pathak (759122)

Subjects:

Effect of CM from osteoblasts cultured with CXCL8 (200 pg/ml) or CCL20 (500 pg/ml) on osteoclastic bone resorption. by Janak L. Pathak (759122)

Subjects:

CXCL8 (200 pg/ml) and CCL20 (500 pg/ml) affected osteoblast-to-osteoclast communication at day 14. by Janak L. Pathak (759122)

Subjects:

Significant decreases in effective connectivity. by Nicola Trotta (424395)

Calpeptin treatment decreases cell density and proliferation. by Daniela M. Santos (211055)

Decreases in muscle size, muscle force, and TB mass in 3-mo Lmna^HSA-cko mice. by Lei Xiong (334812)

%-change after 3 and 12 months of hormone therapy in trans women and trans men. by Moya H. Schutte (12245290)

Subjects:

Lovastatin treatment decreases ICAM-1 and CD11b expression and vascular permeability and induce HMOX-1 expression in the brains of mice with CM. by Patricia A. Reis (109310)

No change in muscle size and force, but a decrease in TB mass in 1-mo Lmna^HSA-cko mice. by Lei Xiong (334812)

Pathophysiological model. by Janak L. Pathak (759122)

Subjects:

Osteoblasts expressed CXCR1 and CCR6 receptors. by Janak L. Pathak (759122)

Subjects:

CXCL8 and CCL20 Enhance Osteoclastogenesis via Modulation of Cytokine Production by Human Primary Osteoblasts by Janak L. Pathak (759122)

Subjects:

Macrophage-secreted factors decrease RBP4 production. by Primoz Kotnik (382835)

PTH decreased cell apoptosis in a Flt-3L expanded population. by Flavia Q. Pirih (360515)

Variable importance plot (mean decrease accuracy and mean decrease Gini). by Fernando Martinez-Taboada (8655132)

Damsin (D) and ambrosin (A) treatment decreases the CSC population. by Wendy Soria Sotillo (4408105)

The distributions of the end-simulation adolescence-limited proportion when (a) <i>k</i> is increased or decreased by 50%, (b) <i>c</i> is increased or decreased by 50%, (c) <i>γ</i> is increased or decreased by 50%, and (d) Δ<i>e</i> is increased or decreased by 50%, compared against the benchmark distribution <i>F</i>(<b>p</b>₀) for the parameters shown in Table 1. by Jia Ning Leaw (752775)

Inflammation and hemostasis markers at 0, 3 and 12 months in trans men (absolute values). by Moya H. Schutte (12245290)

Subjects:

<i>Vps13</i> mutant flies show a decreased life span, age dependent impairment of locomotor function and neurodegeneration. by Jan J. Vonk (3686662)